Palade Particles, 1955

Electron microscopy led to the first identification of what would later be known as ribosomes.

kerry grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ROUGH ER: In 1966, a decade after first describing granules within cells that would come to be known as ribosomes, George Palade generated this transmission electron micrograph of the guinea pig pancreas illustrating the endoplasmic reticulum studded with ribosomes. COURTESY OF YALE UNIVERSITY SCHOOL OF MEDICINEAs biologist James Rothman took the stage in Stockholm last year to accept a Nobel Prize for his work on vesicle transport, he gave credit to the man who used to occupy his office at Yale University. “Certainly the story of the work that led to my contributions begins with George Palade,” Rothman said. A grandfather of the field of cell biology and the founder of Rothman’s department, Palade discovered a process of intracellular transport—the movement of proteins from the endoplasmic reticulum (ER) to the Golgi apparatus and then into secretory vesicles.

In 1974, Palade himself took the stage to deliver his own Nobel lecture. The foundation for much of his work was electron microscopy (EM), which Palade used to visualize the components of the cell. During the 1950s, as a researcher at the Rockefeller Institute for Medical Research (now Rockefeller University) in New York City, Palade was surrounded by the giants of EM—Keith Porter, Albert Claude, and others. As Palade described in his Nobel lecture, their advances in EM led to a “near avalanche of discoveries, rediscoveries, and redefinitions of subcellular components” in the early 1950s.

During this time, Palade and many of his colleagues were particularly interested in the pancreatic acinar cell, a veritable factory of protein synthesis and secretion. With advances in thin sectioning, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours